0,838  0,005  Antihypercholesterolemic
0,779  0,004  Antipyretic
0,761  0,012  Antineoplastic (lung cancer)
0,753  0,014  Antineoplastic (breast cancer)
0,730  0,018  Transcription factor NF kappa B inhibitor
0,729  0,020  Caspase 9 stimulant
0,698  0,031  Apoptosis agonist
0,682  0,016  Antineoplastic (colorectal cancer)
0,668  0,016  Antineoplastic (colon cancer)
0,639  0,009  NOS2 expression inhibitor
0,638  0,012  Sensitization
0,633  0,020  TNF expression inhibitor
0,633  0,045  Antiinflammatory
0,595  0,012  Proliferative diseases treatment
0,574  0,005  P-glycoprotein inhibitor
0,573  0,015  Antineoplastic (cervical cancer)
0,584  0,030  CYP3A4 substrate
0,543  0,015  Ulceration
0,530  0,010  Antimitotic
0,546  0,028  Teratogen
0,519  0,004  Calcium channel activator
0,511  0,006  Antineoplastic (squamous cell carcinoma)
0,512  0,007  Tubulin antagonist
0,528  0,027  Prostate cancer treatment
0,491  0,004  Pneumotoxic
0,517  0,033  CYP2C9 substrate
0,490  0,021  Cytostatic
0,495  0,028  Antineoplastic (ovarian cancer)
0,478  0,017  Hypoxia-inducible factor 1 alpha inhibitor
0,483  0,022  UGT1A9 substrate
0,466  0,009  Hepatoprotectant
0,481  0,025  Hepatic disorders treatment
0,467  0,015  Antidiabetic symptomatic
0,477  0,033  Embryotoxic
0,469  0,025  AR expression inhibitor
0,493  0,057  Antineoplastic (solid tumors)
0,479  0,043  Antileukemic
0,462  0,027  Caspase 3 stimulant
0,443  0,010  Abortion inducer
0,436  0,011  Antineoplastic (carcinoma)
0,449  0,028  NOS3 expression inhibitor
0,470  0,050  Antibacterial
0,442  0,031  Cytotoxic
0,442  0,032  Antineoplastic (melanoma)
0,434  0,030  CTGF expression inhibitor
0,447  0,048  Immunosuppressant
0,434  0,038  Respiratory analeptic
0,422  0,026  UGT2B4 substrate
0,419  0,029  Antineoplastic (non-small cell lung cancer)
0,389  0,005  Expectorant
0,434  0,054  Antipruritic, allergic
0,411  0,036  ICAM1 expression inhibitor
0,404  0,037  Antineoplastic (pancreatic cancer)
0,405  0,039  Spasmolytic
0,391  0,029  Chemopreventive
0,398  0,036  Antineoplastic (glioma)
0,373  0,012  VCAM1 expression inhibitor
0,378  0,023  Antiulcerative
0,402  0,049  Cholesterol antagonist
0,399  0,049  Antithrombotic
0,401  0,055  Vasodilator, peripheral
0,375  0,036  Antineoplastic (multiple myeloma)
0,366  0,030  Sodium/bile acid cotransporter inhibitor
0,368  0,033  Antineoplastic (glioblastoma multiforme)
0,345  0,012  Protein kinase stimulant
0,361  0,030  Nitric oxide antagonist
0,351  0,024  Antineoplastic (sarcoma)
0,336  0,017  Anesthetic
0,361  0,043  Antioxidant
0,369  0,052  Aldehyde oxidase inhibitor
0,363  0,048  Antineoplastic (brain cancer)
0,350  0,038  Cardiovascular analeptic
0,325  0,015  Topoisomerase II inhibitor
0,358  0,049  Lipoxygenase inhibitor
0,325  0,019  Melanin inhibitor
0,323  0,017  Lipocortins synthesis antagonist
0,344  0,039  Antineoplastic (lymphoma)
0,337  0,040  Antineoplastic (endocrine cancer)
0,306  0,018  Lipid peroxidase inhibitor
0,311  0,024  UGT2B7 substrate
0,341  0,054  Analeptic
0,302  0,023  Contraceptive
0,327  0,048  DNA damaging
0,316  0,040  UGT1A6 substrate
0,281  0,011  Antineoplastic antibiotic
0,333  0,064  Vasodilator, coronary
0,317  0,047  Free radical scavenger
0,297  0,033  UGT1A1 substrate
0,262  0,006  Microtubule formation inhibitor
0,259  0,005  Alpha tubulin antagonist
0,329  0,077  Antiallergic
0,289  0,039  Antineoplastic enhancer
0,254  0,005  Beta tubulin antagonist
0,262  0,021  Genotoxic
0,250  0,010  Topoisomerase II alpha inhibitor
0,269  0,033  Antimutagenic
0,276  0,041  UDP-glucuronosyltransferase substrate
0,240  0,005  Antineoplastic (uterine cancer)
0,283  0,048  Carcinogenic
0,300  0,071  Cardioprotectant
0,302  0,076  Antineoplastic (small cell lung cancer)
0,239  0,012  Antieczematic
0,342  0,122  5 Hydroxytryptamine release inhibitor
0,227  0,009  Mucolytic
0,236  0,018  DNA intercalator
0,266  0,050  Mutagenic
0,247  0,031  UGT1A3 substrate
0,257  0,045  RNA-directed DNA polymerase inhibitor
0,275  0,064  Antineoplastic (renal cancer)
0,224  0,015  Arachidonic acid antagonist
0,217  0,014  Cyclooxygenase 3 inhibitor
0,242  0,038  Antipruritic, non-allergic
0,285  0,082  Antineoplastic (osteosarcoma)
0,293  0,090  Apoptosis antagonist
0,288  0,086  Antifungal
0,289  0,092  Bone diseases treatment
0,257  0,060  Cyclic AMP phosphodiesterase inhibitor
0,220  0,024  UGT2B10 substrate
0,257  0,062  DNA synthesis inhibitor
0,262  0,069  Antineoplastic (bladder cancer)
0,258  0,069  Antiprotozoal (Leishmania)
0,245  0,058  Antihypertriglyceridemic
0,210  0,024  Alkylator
0,219  0,036  UGT2B15 substrate
0,262  0,084  Antiosteoporotic
0,182  0,005  Acetylcholine release stimulant
0,227  0,053  Neurotrophic factor enhancer
0,208  0,040  Antiacne
0,243  0,076  Antineoplastic (liver cancer)
0,201  0,035  Phobic disorders treatment
0,192  0,028  Topoisomerase I inhibitor
0,195  0,034  Antifungal enhancer
0,180  0,019  Antineoplastic alkaloid
0,216  0,057  Sigma receptor agonist
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,233  0,078  Antineoplastic (lymphocytic leukemia)
0,247  0,094  CYP2C19 substrate
0,164  0,012  Anabolic
0,241  0,090  5 Hydroxytryptamine uptake stimulant
0,169  0,018  Antiviral (Influenza B)
0,194  0,046  Antirickettsial
0,187  0,040  Aldose reductase substrate
0,240  0,093  Chemoprotective
0,202  0,057  UGT1A4 substrate
0,191  0,048  Antineoplastic (bone cancer)
0,186  0,047  Interferon gamma antagonist
0,185  0,048  UGT2B9 substrate
0,222  0,088  Vasodilator
0,149  0,016  UGT2B11 substrate
0,273  0,140  Histamine release inhibitor
0,152  0,022  Androgen antagonist
0,146  0,017  Antiviral (Trachoma)
0,165  0,037  Antitussive
0,190  0,064  LDLR expression enhancer
0,148  0,022  Antifungal (Pneumocystis)
0,136  0,014  Antiprotozoal activity enhancer
0,181  0,060  Toxic, respiratory center
0,212  0,091  Antihypotensive
0,175  0,053  NOS3 expression enhancer
0,178  0,059  Prostate disorders treatment
0,147  0,033  Photosensitizer
0,181  0,068  Antineoplastic (gastric cancer)
0,168  0,056  Amylase inhibitor
0,160  0,049  Antiseptic
0,263  0,152  Antiprotozoal
0,176  0,069  Liver fibrosis treatment
0,202  0,098  Antiamyloidogenic
0,145  0,045  Growth stimulant
0,119  0,019  Glycine receptor antagonist
0,193  0,092  Antiparasitic
0,114  0,015  Aldose reductase inhibitor
0,111  0,012  Androgen agonist
0,184  0,085  Antiviral (Influenza)
0,273  0,175  Antiarthritic
0,144  0,048  Cholesterol synthesis inhibitor
0,120  0,027  Antibiotic
0,137  0,045  Contraceptive female
0,121  0,029  SULT1E1 substrate
0,168  0,077  3C-like protease (Human coronavirus) inhibitor
0,143  0,053  DNA polymerase I inhibitor
0,207  0,118  Radioprotector
0,164  0,076  Prostatic (benign) hyperplasia treatment
0,113  0,025  Contraceptive male
0,111  0,025  Keratolytic
0,168  0,083  Succinate dehydrogenase inhibitor
0,092  0,008  Lipocortins synthesis agonist
0,113  0,029  Interleukin 5 antagonist
0,137  0,055  Vanilloid 1 agonist
0,206  0,125  Tyrosine 3 hydroxylase inhibitor
0,162  0,082  ATPase inhibitor
0,194  0,115  Vascular (periferal) disease treatment
0,171  0,093  Anesthetic general
0,190  0,112  Peptidyltransferase inhibitor
0,125  0,049  Choleretic
0,183  0,107  Hypolipemic
0,122  0,046  Multidrug resistance-associated protein 1 inhibitor
0,124  0,048  Estrogen antagonist
0,081  0,006  Pregnane X receptor antagonist
0,121  0,047  UGT2B1 substrate
0,100  0,026  HIV-1 integrase (3'-Processing) inhibitor
0,092  0,019  Estrogen agonist
0,189  0,119  Tumour necrosis factor alpha release inhibitor
0,093  0,023  Aromatase inhibitor
0,135  0,066  Cocaine dependence treatment
0,220  0,151  GST M1-1 substrate
0,132  0,065  Antihyperlipoproteinemic
0,244  0,179  CYP2C19 inhibitor
0,077  0,013  Glucose-6-phosphate translocase inhibitor
0,160  0,098  Antihelmintic
0,142  0,080  Antiviral (Influenza A)
0,126  0,065  Coagulant
0,118  0,058  Endometrios treatment
0,082  0,022  Postmenopausal disorders treatment
0,103  0,043  Actinic keratosis treatment
0,081  0,023  SULT2A1 substrate
0,113  0,055  Antiprotozoal (Toxoplasma)
0,064  0,010  Glucocorticoid antagonist
0,139  0,086  Heat shock protein 90 antagonist
0,158  0,105  Non-steroidal antiinflammatory agent
0,244  0,191  Alpha-glucosidase inhibitor
0,082  0,030  HIV-1 integrase (Strand Transfer) inhibitor
0,084  0,033  Antitreponemal
0,064  0,015  5-Alpha-reductase inhibitor
0,097  0,048  Ornithine decarboxylase inhibitor
0,110  0,062  Antiviral (SARS coronavirus)
0,110  0,062  Antiviral (Coronavirus)
0,104  0,057  Estrogen receptor beta antagonist
0,066  0,019  Topoisomerase II beta inhibitor
0,112  0,068  TRPA1 agonist
0,067  0,024  Postcoital contraceptive
0,216  0,176  Antiprotozoal (Plasmodium)
0,057  0,018  Microtubule stabilization
0,064  0,028  Protein 50S ribosomal subunit inhibitor
0,196  0,160  CYP1A2 substrate
0,080  0,046  Narcotic antagonist
0,081  0,047  Estrogen receptor alpha antagonist
0,188  0,155  CYP2D6 substrate
0,034  0,005  Glucocorticoid agonist
0,091  0,064  Breast cancer-resistant protein inhibitor
0,142  0,116  Platelet adhesion inhibitor
0,140  0,114  Sedative
0,053  0,027  Factor III inhibitor
0,103  0,077  Electron transport complex I inhibitor
0,086  0,063  ATPase (Vacuolar H+) inhibitor
0,060  0,037  Ryanodine receptor antagonist
0,118  0,096  Hair growth stimulant
0,240  0,217  Calcium channel L-type activator
0,068  0,047  Andropause treatment
0,131  0,110  Heat shock protein 90 alpha antagonist
0,109  0,090  Acetylcholinesterase inhibitor
0,027  0,009  Corticosteroid-like
0,113  0,096  Interleukin 4 antagonist
0,043  0,026  Hypogonadism treatment
0,038  0,022  Estrogen receptor alpha agonist
0,094  0,080  Monophenol monooxygenase inhibitor
0,149  0,135  Insulin sensitizer
0,035  0,022  Tubulin agonist
0,095  0,083  Cystathionine beta-synthase inhibitor
0,097  0,086  Anesthetic local
0,179  0,169  Transcription factor STAT inhibitor
0,038  0,028  Vesicle monoamine transporter inhibitor
0,102  0,093  Interleukin 8 antagonist
0,093  0,085  Protein-tyrosine phosphatase 1B inhibitor
0,105  0,097  Toll-Like receptor 2 antagonist
0,120  0,113  Eye irritation, high
0,082  0,077  Paget's disease treatment
0,087  0,082  Chronic obstructive bronchitis treatment
0,062  0,059  Hypercalcemia treatment
0,122  0,119  Adenylate cyclase stimulant
0,156  0,153  VEGF expression inhibitor
0,025  0,024  RNA-directed RNA polymerase stimulant
0,057  0,055  Nitric oxide donor
0,085  0,085  Sulfotransferase substrate

